A Phase 2 interventional study of somatropin in Bone Fracture and Tibia Fractures, sponsored by Novo Nordisk A/S. Completed at 40 sites in 9 countries. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-01-23.
Sponsored by Novo Nordisk A/S · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 38 studies in Fractures, Bone with a site in Germany — 6 open to participants now, 9 under way, none of them phase 3. Fractures, Bone · Germany.
Among the 38 studies in Fractures, Bone with a site in Germany, this one is the 6th largest by enrollment of the 19 interventional ones that give a count, is the only one that started in 2001, is one of 4 in phase 2, and was the 4th registered.
725 studies on the registry are indexed under Fractures, Bone; 116 are open to participants now.
Browse Fractures, Bone studies →6 of the 38 studies in Fractures, Bone with a site in Germany are open now. Recruiting first, the newest first:
Amber Implants B.V. · Sites in Germany, France
Ages 21–85
AO Innovation Translation Center · Sites in Germany, United States, Austria and 1 more country
Ages 18+
University Hospital Augsburg · Sites in Germany
Ages 18+
Exactech · Sites in Germany, United States, Canada and 3 more countries
Ages 21+
Rigshospitalet, Denmark · Sites in Germany, Argentina, Austria and 33 more countries
Ages 16+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 72 Fractures, Bone studies recruiting now, 36 (50%) set no upper age limit and 22 (31%) stop at 75 or younger; 17 take children under 18; 14 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 5 · Phase 3 3 · Phase 4 2
First in 1994; this study’s year is marked. 1 started in 2001.
This study's enrollment of 407 is above the median of 80 across 458 interventional studies indexed under Fractures, Bone.
Median enrollment 148 across the 19 interventional studies, 210 across the 19 observational. Of the 27 that completed or were terminated, 4 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
21 of 38 have an industry lead sponsor. The 10 most frequent:
Novo Nordisk A/S is the lead sponsor of 1,411 studies on the registry; 108 are open to participants now.
Of its 205 completed or terminated interventional studies of FDA-regulated products, 101 (49%) have results posted.
Novo Nordisk A/S has 1 study filed under Fractures, Bone — fewer than ten, so there is no comparison to draw.
3 of the studies in Fractures, Bone with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04921865AO Innovation Translation CenterCase Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems | 2027-01-31 |
| NCT06910618Buda Health CenterA Multicenter Prospective Observational Study on Vertebral Fracture Risk Stratification in Patients With Vertebral Metastases | 2027-04-01 |
| NCT07301749Amber Implants B.V.A Clinical Study Evaluating the Safety and Efficacy of the VCFix Spinal System for Treatment of Vertebral Compression Fractures | 2027-07-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 38 studies in Fractures, Bone with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This trial is conducted in Africa, Europe and Middle East. This trial investigates the efficacy and safety of three dose levels of Norditropin® (growth hormone) as compared to placebo in the treatment of tibia fractures. The trial will be conducted in two parts: in the first part, the patients will be evaluated with regard to efficacy (fracture healing) and safety at short time intervals until week 24 post-surgery. In the second part, long-term safety and fracture healing up to 12 months post-surgery will be evaluated.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Time from surgery until fracture has healed
Time frame: During a 12 month period
Investigator's assessment: fracture healed
Number of fractures healed
The record gives a start of Aug 2001, a primary completion of Oct 2003 and a completion of Oct 2003. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Human Growth Hormone